Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the ...

Cancer’s deadliest talent is not rapid growth but the ability to sidestep the internal programs that should make damaged cells self-destruct. Across multiple labs, researchers are now converging on a ...

Innovative diagnostic approaches: Serum protein markers in renal cell carcinoma. Comprehensive proteomic profiling of plasma samples associated with response or resistance to immune checkpoint ...

Breast cancer's resistance to treatment is a major hurdle in improving patient outcomes. A recent study explores how tumor angiogenesis—the formation of abnormal blood vessels in tumors—plays a ...

Breast cancer, the most common cancer among women, is notorious for its ability to develop resistance to a wide range of treatments, including surgery, chemotherapy, targeted therapies, and ...

Baseline heterogeneity of myeloid and stroma cells to predict pCR, baseline lymph node (LN) metastasis, and 1-year EFS in locally advanced ESCC with neoadjuvant immunotherapy: Final results from a ...